Long-Term Response to Single-Agent Lenalidomide in an Elderly Patient with Relapsed Hepatosplenic T-Cell Lymphoma

Online Makale

Online Hizmetlere Toplu Bakış Online Kayıt ve Konaklama Online Bilimsel Program Dernekler İçin... Referanslarımız Telefon ve e-posta Desteği Bildiri özeti nedir? Bildiri özeti nasıl hazırlanır? Bildiri özeti örnekleri Kabul mektubu örnekleri

Turkish Journal of Hematology

Long-Term Response to Single-Agent Lenalidomide in an Elderly Patient with Relapsed Hepatosplenic T-Cell Lymphoma [Turk J Hematol]

Turk J Hematol. Ahead of Print: TJH-32748 | DOI: 10.4274/tjh.galenos.2025.2025.0252

Long-Term Response to Single-Agent Lenalidomide in an Elderly Patient with Relapsed Hepatosplenic T-Cell Lymphoma

Süreyya Yiğit Kaya¹, Rima Akil¹, Gülşah Akyol², Amir Hossein Abedi³, Serhat Çelik⁴, Leylagül Kaynar¹
¹İstanbul Medipol University Faculty of Medicine, Department of Hematology, İstanbul, Türkiye
²Erciyes University Faculty of Medicine, Department of Hematology, Kayseri, Türkiye
³İstanbul Medipol University Faculty of Medicine, Department of Internal Medicine, İstanbul, Türkiye
⁴Yıldırım Beyazıt University, Yenimahalle Training and Research Hospital, Department of Hematology, Ankara, Türkiye

Keywords: Hepatosplenic T-cell lymphoma, Lenalidomide, Peripheral T-cell lymphoma, Elderly patient

Corresponding Author: Süreyya Yiğit Kaya

TOOLS